Skip to main content

Month: April 2021

Inovalon Announces 2021 Virtual Investor Day

BOWIE, Md., April 29, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will host a virtual Investor Day on Tuesday, May 18, 2021 beginning at 10 a.m. ET. The virtual Investor Day is expected to run approximately 2.5 hours. Executives from Inovalon will provide an overview and discussion of the Company’s vision, growth strategy, markets, cloud-based platform capabilities, and financial information. Inovalon will webcast the event on the Investor Relations section of its website at www.inovalon.com. A replay of the event as well as a copy of all presentation materials will be available on its website following the event. About Inovalon Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through...

Continue reading

OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time

GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first quarter 2021 financial results before the open of the U.S. financial markets on Thursday, May 13, 2021. OpGen’s management team will host a live conference call and audio webcast at 8:30 a.m. Eastern Time to discuss the Company’s financial results and provide an update on business activities.Conference Call DetailsU.S. Dial-in Number:International Dial-in Number:Webcast:Conference ID: +1 (877) 705 6003+1 (201) 493 6725http://public.viavid.com/index.php?id=14474913719409   Replay DetailsU.S. Dial-in Number:International Dial-in Number:Replay PIN: +1 (844) 512 2921+1 (412) 317 667113719409Following the conclusion of the conference...

Continue reading

WisdomTree expands digital assets range with Ethereum ETP launch

Ethereum ETP (ETHW) lists on SIX and Börse Xetra NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — WisdomTree, the exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor, has announced the expansion of its digital assets range with the launch of a physically-backed1 ether ETP. The WisdomTree Ethereum ETP (ETHW) listed today on Börse Xetra and SIX, the Swiss Stock Exchange. WisdomTree now offers the lowest priced physically-backed ether and bitcoin ETPs in Europe, both with a total expense ratio of 0.95% and passported across the European Union. WisdomTree Ethereum provides investors with a simple, secure and cost-efficient way to gain exposure to the price of ether, the native currency of the Ethereum network, while utilising the best of traditional financial infrastructure and product structuring....

Continue reading

Achiko’s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration

Achiko AG’s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution CertificateAchiko Subsequently Commenced Product Registration with its Partners with a View to Mid-Year Commercial Product AvailabilityAchiko to Generate Revenues on a 50% Holding of the Joint Venture and a 10% Licensing Fee from Gross SalesZURICH, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) — Achiko AG’s (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis (“IFM”) has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX. This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration...

Continue reading

Kura Oncology to Report First Quarter 2021 Financial Results

SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2021 financial results after the close of U.S. financial markets on Thursday, May 6, 2021. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing (888) 771-4371 for domestic callers and (847) 585-4405 for international callers and entering the conference code: 50156205. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.kuraoncology.com.        About...

Continue reading

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2021 Earnings and Company Updates

CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present its first quarter 2021 financial results and operational highlights in a conference call on May 6 at 8 a.m. E.T. To join the call:U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference call.A replay of the call will be available through the Events and Presentations page of the Investors & Media section of the company’s website at www.intelliatx.com, beginning on May 6 at 12 p.m. E.T. About Intellia TherapeuticsIntellia...

Continue reading

Kelly® Announces First Quarter Conference Call

TROY, Mich., April 29, 2021 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA) (Nasdaq: KELYB), a leading specialty talent solutions provider, will release its first quarter earnings before the market opens on Thursday, May 13, 2021. In conjunction with its first quarter earnings release, Kelly will publish a financial presentation on the Investor Relations page of its public website and will host a conference call at 9 a.m. ET. The call may be accessed in one of the following ways: Via the Internet:Kellyservices.com Via the Telephone: (877) 692-8955 (toll free) or (234) 720-6979 (caller paid)Enter access code 5728672After the prompt, please enter “#” A recording of the conference call will be available after 2:30 p.m. ET on May 13, 2021 at (866) 207-1041 (toll-free) and (402) 970-0847 (caller-paid). The access code is 2456495#. The recording...

Continue reading

Kinross to redeem $500 million in Senior Notes on June 1, 2021

(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.) TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX:K; NYSE:KGC) (“Kinross”) announced today it will redeem all of the outstanding 5.125% Senior Notes due September 1, 2021 (the “Notes”), which have an aggregate principal amount of $500 million, on June 1, 2021 (the “Redemption Date”). The Notes will be redeemed at a redemption price equal to the principal amount of the outstanding Notes plus accrued and unpaid interest to, but not including, the Redemption Date, in accordance with the terms of the Notes. Interest on the Notes will cease to accrue from and after the Redemption Date. After the Notes are redeemed, $1,250 million in aggregate principal amount of Kinross Senior Notes will remain outstanding, with the next maturity date...

Continue reading

Dynacor Receives TSX Approval to Renew Normal Course Issuer Bid

MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG / OTC: DNGDF) (Dynacor or the Corporation) is pleased to announce that the Toronto Stock Exchange (TSX) has approved the Corporation’s request to renew a normal course issuer bid (NCIB) program, through which Dynacor may purchase, for cancellation, up to 3,111,165 common shares or approximately 10% of the public float (31,111,651 common shares as of April 20, 2021). Dynacor is in a financially strong position to continue to return a portion of its cash to its shareholders through the NCIB. Additionally, it is reviewing other value-added opportunities which could further contribute to enhancing shareholder value. The Corporation may purchase shares under the NCIB over a period of twelve months commencing on May 3, 2021 and ending May 2, 2022, when...

Continue reading

FTI Consulting Reports Record First Quarter 2021 Financial Results

First Quarter 2021 Revenues of $686.3 Million, Up 13.5% Compared to $604.6 Million in Prior Year Quarter First Quarter 2021 EPS of $1.84, Up 23.5% Compared to $1.49 in Prior Year Quarter; First Quarter 2021 Adjusted EPS of $1.89, Up 23.5% Compared to $1.53 in Prior Year QuarterWASHINGTON, April 29, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today released financial results for the quarter ended March 31, 2021. First quarter 2021 revenues of $686.3 million increased $81.7 million, or 13.5%, compared to revenues of $604.6 million in the prior year quarter. Excluding the estimated positive impact from foreign currency translation (“FX”), revenues increased $67.0 million, or 11.1%, compared to the prior year quarter. Acquisition-related revenues contributed $16.0 million in the quarter. Excluding the estimated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.